Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 Sep;52(611):587–592. doi: 10.1136/pgmj.52.611.587

Prospects for new vaccines.

A J Beale
PMCID: PMC2495901  PMID: 824636

Full text

PDF
587

Images in this article

590Fig. 1
on p.590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arko R. J. Implantation and use of a subcutaneous culture chamber in laboratory animals. Lab Anim Sci. 1973 Feb;23(1):105–106. [PubMed] [Google Scholar]
  2. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  3. Bowen W. H., Cohen B., Cole M. F., Colman G. Immunization against dental caries. Br Dent J. 1975 Jul 15;139(2):45–58. [PubMed] [Google Scholar]
  4. Erwa H. H., Haseeb M. A., Idris A. A., Lapeyssonnie L., Sanborn W. R., Sippel J. E. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Bull World Health Organ. 1973;49(3):301–305. [PMC free article] [PubMed] [Google Scholar]
  5. Gold R., Artenstein M. S. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ. 1971;45(3):279–282. [PMC free article] [PubMed] [Google Scholar]
  6. Hughes M., Thomson R. O., Knight P., Stephen J. The immunopurification of tetanus toxoid. J Appl Bacteriol. 1974 Dec;37(4):603–621. doi: 10.1111/j.1365-2672.1974.tb00485.x. [DOI] [PubMed] [Google Scholar]
  7. Jones R. J., Roe E. A., Lowbury E. J., Miler J. J., Spilsbury J. F. A new Pseudomonas vaccine: preliminary trial on human volunteers. J Hyg (Lond) 1976 Jun;76(3):429–439. doi: 10.1017/s0022172400055364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marmion B. P., Tonkin R. W. Control of hepatitis in dialysis units. Br Med Bull. 1972 May;28(2):169–179. doi: 10.1093/oxfordjournals.bmb.a070919. [DOI] [PubMed] [Google Scholar]
  9. McCahon D., Beare A. S., Schild G. C., Hall T. S. Use of recombination in the production of influenza vaccine strains. Postgrad Med J. 1973 Mar;49(569):195–199. doi: 10.1136/pgmj.49.569.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  11. Morris C. A., Freestone D. S., Stealey V. M., Oliver P. R. Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity, and transmissibility. Lancet. 1975 Aug 2;2(7927):196–199. doi: 10.1016/s0140-6736(75)90670-4. [DOI] [PubMed] [Google Scholar]
  12. Murphy B. R., Richman D. D., Spring S. B., Chanock R. M. Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children. Postgrad Med J. 1976 Jun;52(608):381–388. doi: 10.1136/pgmj.52.608.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mäkelä P. H., Käyhty H., Weckström P., Sivonen A., Renkonen O. V. Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet. 1975 Nov 8;2(7941):883–886. doi: 10.1016/s0140-6736(75)92125-x. [DOI] [PubMed] [Google Scholar]
  14. Novotny P., Short J. A., Walker P. D. An electron-microscope study of naturally occurring and cultured cells of Neisseria Gonorrhoeae. J Med Microbiol. 1975 Aug;8(3):413–427. doi: 10.1099/00222615-8-3-413. [DOI] [PubMed] [Google Scholar]
  15. Pierce N. F., Gowans J. L. Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med. 1975 Dec 1;142(6):1550–1563. doi: 10.1084/jem.142.6.1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pierce N. F., Reynolds H. Y. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization. J Immunol. 1974 Sep;113(3):1017–1023. [PubMed] [Google Scholar]
  17. Powell P. C. Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines. Nature. 1975 Oct 23;257(5528):684–685. doi: 10.1038/257684a0. [DOI] [PubMed] [Google Scholar]
  18. Stevens D. A., Jordan G. W., Waddell T. F., Merigan T. C. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med. 1973 Oct 25;289(17):873–878. doi: 10.1056/NEJM197310252891701. [DOI] [PubMed] [Google Scholar]
  19. Turner W. H., Novotny P. The inability of Neisseria gonorrhoeae pili antibodies to confer immunity in subcutaneous guinea-pig chambers. J Gen Microbiol. 1976 Jan;92(1):224–228. doi: 10.1099/00221287-92-1-224. [DOI] [PubMed] [Google Scholar]
  20. Wahdan M. H., Rizk F., el-Akkad A. M., el-Ghoroury A. A., Hablas R., Girgis N. I., Amer A., Boctar W., Sippel J. E., Gotschlich E. C. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull World Health Organ. 1973 Jun;48(6):667–673. [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES